Hormone Therapy gets Resounding Endorsement 10 years after WHI Study
by D.C. Tworek, NASM CPT, Nutrition Specialist
The stigma surrounding hormone therapy has slowly wafted into a mere dust clouds as more and more research unravels the findings of the Women’s Health Initiative (WHI) published ten years ago on July 9. Today, at least 15 major medical organizations endorse hormone therapy as a viable option for the treatment of menopause.
The WHI study was the first of its kind, designed to test the safety and efficacy of hormone therapy for disease prevention and symptom relief in menopausal women. As the years ticked by, the long-term study was yielding startling results, prompting an immediate halt and reverberated fear in millions of women and health practitioners across the globe.
Over the last ten years, however, multiple analyses and additional studies have re-examined the WHI results and tested many of the conclusions, finding design flaws in the study and irrefutable evidence that the benefits of hormone therapy far outweigh the truly minimal risks. In statements released earlier this week, major medical organizations, such as the North American Menopause Society (NAMS), the American Society for Reproductive Medicine (ASRM) and The Endocrine Society, along with 12 other medical organizations, put their stamp of approval on hormone therapy for women.
Women may now rest assured – effective relief of symptoms of menopause is safe. The expert physicians of BodyLogicMD understand this better than anyone – offering tailored programs combining bioidentical hormone therapy with fitness, nutrition and stress management for optimal health outcomes.